Streetbeat News

Partnerships

LLY

VERV

Verve Therapeutics announced an exclusive research collaboration with Eli Lilly to advance Verve's preclinical stage in vivo gene editing program targeting lipoprotein. This partnership has led to an increase in Verve's stock price.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:46 pm

CGRN

Capstone Green Energy Corporation (NASDAQ:CGRN) announced that its distributor, E-Finity Distributed Generation, secured a follow-on order for ten Capstone C65 microturbines from a leading oil and gas producer in the Marcellus Shale region. The microturbines will provide primary electrical power at various wellhead sites and maintain ultra-low site emissions.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:35 pm

SOFO

Sonic Foundry's Vidable business plans to partner with its Video Solutions business to develop AI-powered analytics and transformation solutions for the events market. This follows a partnership with CTI Meeting Technology and discussions at MPI WEC23, validating the market opportunity for events-oriented video AI.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:21 pm

VQS

VIQ Solutions has partnered with Justice AV Solutions to provide AI-generated draft transcripts of courtroom proceedings, leading to an increase in VIQ Solutions' share price.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:19 pm

CBAT

CBAK Energy Technology (NASDAQ:CBAT) has received an order worth €116.5 million for lithium-ion batteries from Viessmann Group for 2024. This brings the total order value from Viessmann in 2022 and 2023 to approximately €176.1 million.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:10 pm

GETR

Getaround, a car-sharing platform, has partnered with Axle to allow guests to use their own car insurance, reducing costs for both guests and car owners. This partnership aims to make car-sharing more accessible and affordable.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:09 pm

VBIV

VBI Vaccines announced that its 3-antigen hepatitis B vaccine, PreHevbri, is now available in the UK for adults. The vaccine will be launched through a marketing and distribution partnership with Valneva.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:06 pm

FBIO

Helocyte, a subsidiary of Fortress Biotech, announced that the National Cancer Institute has awarded a $3.22 million grant to City of Hope for clinical studies of Triplex, a cytomegalovirus vaccine being developed by Helocyte and City of Hope.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:04 pm

ACN

Accenture has invested in New York-based virtual reality company Praxis Labs, which focuses on improving equity and inclusion through immersive workplace scenarios in VR/MR. The terms of the investment were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:01 pm